Wellnex Life Shortfall Placement

Wellnex Life* Shortfall Placement

This Offer Is Now Closed

Placement Details

Offer Price

$0.15

*Offer is at the same price as the institutional placement.

Wellnex Life (WHA) is well-positioned to capture market share in the multi-billion-dollar health & wellness sector. We have a pathway to ongoing profitability in an industry that’s growing locally and globally, and the right capital structure and management team in place to take full advantage of future opportunities for Wellnex Life.

George Karafotias, CEO

Speak to an Advisor

What is a 708 investor?

By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Corporate are engaged as the Corporate Advisor for WHA and may receive fees depending on whether an offer is taken up by investors.

Company Overview

Wellnex Life is a specialist Australian brand and distribution company that is focused on consumer health & wellness products. The company is on a mission to deliver health, wellness and vitality products to consumers in a fast-growing market sector. Bringing product innovation capabilities and an established retail distribution network, Wellnex Life is uniquely positioned to be a disruptive player and leader in the health & wellness market. 

Close

Speak to An Advisor



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets are the advisors assisting with the management of this offer and may receive fees depending on whether an offer is taken up by investors.

Investment
Highlights

  • The shortfall offer price is $0.15 per share
  • Funds raised will be used to expand on current business opportunities and as general working capital
  • The company’s annualised revenue has grown from $5 million to $15 million in 2020 and is expected to exceed $18 million in 2021
  • The global wellness economy was valued at US$4.5 trillion in 2018 growing from $3.7 trillion in 2015
  • 10-year guaranteed supply agreement secured with Chemist Warehouse that ensures brands move from production line to retail shelves
  • Joint venture agreements with distributors to develop brands and products – an opportunity to strengthen and expand distributor relationships

Company Presentation

June 28th, 2021

In this video, Wellnex Life’s Chief Executive Officer George Karafotias and Executive Director Zack Bozinovski discussed:

  • How the company is on track to take full advantage of its expanded portfolio of brands
  • How the company is well-placed to capture spend from the US$4.5 trillion global wellness market
  • How the team is positioning itself with the right financial structure and management to capitalise on one of Australia’s fast growing sectors

Wellnex Life Shortfall Placement

Offer Price

$0.15

*Offer is at the same price as the institutional placement

Investor Presentation

A New Path Forward

“As Wattle Health Australia (WHA) rebrands as Wellnex Life (WNX) I believe the company is well-positioned to capitalise on the multi-billion-dollar health & wellness sector. We have a pathway to ongoing profitability in an industry that’s growing locally and globally, and the right capital structure and management team in place to take full advantage of future opportunities for Wellnex Life.”

George Karafotias – CEO

Speak to an Advisor

What is a 708 investor?

By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Corporate are engaged as the Corporate Advisor for WHA and may receive fees depending on whether an offer is taken up by investors.

*Previously Wattle Health Australia